Salts and Derivatives of Active Pharmaceutical Ingredients (API)
The salts of Active Pharmaceutical Ingredients (APIs) are compounds formed by the reaction of an acid with a base, resulting in an ionic equilibrium. These salts often improve the solubility and stability of APIs, facilitating their absorption in the body. API derivatives are chemical variants of an active ingredient that may have enhanced or modified properties to optimise therapeutic efficacy. API salts are used in the formulation of oral, injectable, and topical medications. Additionally, API derivatives can improve the pharmacokinetics of drugs, such as enabling controlled release of active substances.
At CymitQuimica, we provide API salts and derivatives with the necessary purity and quality for research and pharmaceutical formulation development.
Found 79283 products of "Salts and Derivatives of Active Pharmaceutical Ingredients (API)"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Benzphetamine Related Compound A CIII ((R)-N-Benzyl-N-methyl-1-phenylpropan-2-amine hydrochloride)
CAS:Controlled Product<p>Aromatic monoamines not elsewhere specified or included and their derivatives, salts therof</p>Formula:C17H21N·HClColor and Shape:White Off-White PowderMolecular weight:275.14408DQP-26
CAS:<p>DQP-26, a potent negative allosteric modulator of NMDA receptors (NMDARs), exhibits IC50 values of 0.77 μM for GluN2C and 0.44 μM for GluN2D subunits,</p>Formula:C28H21Cl2N3O4Purity:98%Color and Shape:SolidMolecular weight:534.39BMT-108908
CAS:<p>BMT-108908 is a Negative Allosteric Modulator. It is selective for the NR2B Subtype of The NMDA Receptor Impair Cognition in Multiple Domains.</p>Formula:C22H25FN2O2Color and Shape:SolidMolecular weight:368.44BMS-986169
CAS:<p>BMS-986169 is a high-affinity and selective negative allosteric modulator of the NMDA receptor GluN2B subunit, depression.</p>Formula:C23H27FN2O2Purity:97.61%Color and Shape:SolidMolecular weight:382.47Pregnanolone sulfate (pyridinium)
CAS:<p>Pregnanolone sulfate pyridinium, an endogenous neurosteroid, inhibits NMDA receptors and exhibits neuroprotective properties [1].</p>Formula:C26H39NO5SPurity:98%Color and Shape:SolidMolecular weight:477.66Risevistinel
CAS:<p>Risevistinel (NYX-783), a positive allosteric modulator of the N-methyl-D-aspartate (NMDA) receptor, may mitigate cognitive deficits in neurodegenerative</p>Formula:C14H23N3O4Purity:98%Color and Shape:SolidMolecular weight:297.35(R)-3,4-DCPG
CAS:<p>AMPA receptor antagonist with weak activity at NMDA receptors and little activity at kainate receptors</p>Formula:C10H9NO6Purity:98%Color and Shape:SolidMolecular weight:239.18Nevadistinel
CAS:<p>Nevadistinel (NYX-458; NYX-3054) is a positive allosteric modulator of the N-methyl-D-aspartate (NMDA) receptor, indicated for mitigating cognitive deficits</p>Formula:C15H18N2O3Purity:98%Color and Shape:SolidMolecular weight:274.32Dasolampanel etibutil
CAS:<p>Dasolampanel etibutil is a novel selective antagonist of ionotropic glutamate receptor 5 (iGluR5).</p>Formula:C23H32ClN5O3Color and Shape:SolidMolecular weight:461.98p-fin4
CAS:<p>p-fin4, a peptide, inhibits STEP-GluA2 interaction, Ki 0.4 μM; may enhance cognition, has anxiolytic and antidepressant effects.</p>Formula:C39H53N8O18PColor and Shape:SolidMolecular weight:952.85Zelquistinel
CAS:<p>Zelquistinel, an NMDA receptor agonist, aids research on depression, anxiety, and psychiatric disorders.</p>Formula:C15H25N3O5Color and Shape:SolidMolecular weight:327.38NPEC-caged-(S)-AMPA
CAS:<p>AMPA receptor agonist</p>Formula:C16H17N3O8Purity:98%Color and Shape:SolidMolecular weight:379.32GNE-0723
CAS:<p>GNE-0723 is a selective positive allosteric modulator of the NMDA receptor, GluN2A.blood-brain barrier (BBB) and Dravet syndrome and Alzheimer's disease (AD).</p>Formula:C16H8ClF6N5OSPurity:97.29% - 99.91%Color and Shape:SolidMolecular weight:467.78TCS 46b
CAS:<p>TCS 46b is a NR1A/NR2B NMDA receptor antagonist with oral activity.</p>Formula:C22H23N3OPurity:99.78% - 99.78%Color and Shape:SolidMolecular weight:345.44Naspm trihydrochloride
CAS:<p>Naspm trihydrochloride (1-Naphthylacetyl spermine trihydrochloride) is a synthetic analogue of Joro spider toxin and is an antagonist of calcium permeable AMPA</p>Formula:C22H37Cl3N4OPurity:99.75%Color and Shape:SolidMolecular weight:479.91UBP316
CAS:<p>GluR5-containing kainate receptor antagonist</p>Formula:C20H19N3O6SPurity:98%Color and Shape:SolidMolecular weight:429.45NS1219
CAS:<p>NS1219, an isomer of NS1209, is a selective AMPA antagonist for studying stroke, neuropathic pain, and epilepsy.</p>Formula:C24H28N4O7SColor and Shape:SolidMolecular weight:516.57AMPA receptor modulator-5
CAS:<p>AMPA Receptor Modulator-5 (Example 217) serves as an AMPA receptor modulator, utilized in neurological disease research [1].</p>Formula:C20H12F4N6Purity:98%Color and Shape:SolidMolecular weight:412.34AMPA receptor modulator-6
CAS:<p>AMPA receptor modulator-6, an AMPA receptor positive allosteric modulator (PAM), is utilized in the research of neurological diseases [1].</p>Formula:C24H36N2O4S2Purity:98%Color and Shape:SolidMolecular weight:480.68NMDA receptor modulator 4
CAS:<p>NMDA receptor modulator 4 (Compound 169) can be used for the research of neurological disorder that is a potent modulator of NMDA receptor [1].</p>Formula:C13H9F3N2O3SColor and Shape:SolidMolecular weight:330.28AMPA-IN-1
CAS:<p>AMPA-IN-1: Potent AMPA receptor inhibitor; key in regulating brain excitatory transmission and plasticity.</p>Formula:C23H12F2N4O2Color and Shape:SolidMolecular weight:414.36PF-4778574
CAS:<p>PF-4778574 is a positive AMPA receptor allosteric modulation (EC50: 45 to 919 nM in different cells).</p>Formula:C19H22N2O3S2Purity:98%Color and Shape:SolidMolecular weight:390.52ADCI
CAS:<p>ADCI inhibits voltage-activated sodium and NMDA channels; boosts dopamine metabolism in prefrontal cortex and nucleus accumbens.</p>Formula:C16H14N2OPurity:98%Color and Shape:SolidMolecular weight:250.3NMDA receptor modulator 6
CAS:<p>NMDA receptor regulator 6 (Compound 183) is an effective NMDA receptor regulator and has research value in neurological disorders.</p>Formula:C20H17FN2O4SColor and Shape:SolidMolecular weight:400.42AMPA receptor modulator-2
CAS:<p>AMPA receptor modulator-2 is a modulator of AMPA receptor. The pIC50 value for TARPγ2 dependent AMPA receptor is 10.1.</p>Formula:C15H6F6N4OSPurity:99.8%Color and Shape:SolidMolecular weight:404.29AMPA receptor antagonist-3
CAS:<p>AMPA receptor antagonist-3 is an AMPA receptor antagonist.</p>Formula:C20H19N5O2SPurity:99.79%Color and Shape:SolidMolecular weight:393.46Rislenemdaz
CAS:<p>Rislenemdaz (CERC-301) (CERC-301) is an antagonist of the N-methyl-D-aspartate (NMDA) receptor subunit 2B (GluN2B).</p>Formula:C19H23FN4O2Purity:98.18%Color and Shape:SolidMolecular weight:358.41AMPA receptor modulator-1
CAS:<p>AMPA receptor modulator-1 can be activated by glutamate, thereby modulating ion channels.</p>Formula:C16H11ClF3NO2Purity:99.93%Color and Shape:SolidMolecular weight:341.71N1-N2-Di-N-Nitroso methyl (2S,5S)-5-methylpiperazine-2-carboxylate
Formula:C7H12N4O4Molecular weight:216.22,2'-(Thiobis(2-hydroxy-5,1-phenylene))bis(4H-benzo[e][1,3]oxazin-4-one)
CAS:<p>Please enquire for more information about 2,2'-(Thiobis(2-hydroxy-5,1-phenylene))bis(4H-benzo[e][1,3]oxazin-4-one) including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formula:C28H16N2O6SPurity:Min. 95%Molecular weight:508.5 g/mol13-O-Desmethyl tacrolimus
CAS:<p>Tacrolimus is a macrolide immunosuppressant that is used to prevent organ rejection in transplant patients. It binds to the cytosolic protein, FKBP-12, which prevents calcineurin from dephosphorylating and activating nuclear factor of activated T cells (NFAT). Tacrolimus inhibits the production of IL-2 and other cytokines by T cells, suppressing proliferation. Tacrolimus has been shown to be bioequivalent when administered orally or intravenously. Bioavailability may be increased when taken with food.</p>Formula:C43H67NO12Purity:90%MinColor and Shape:PowderMolecular weight:789.99 g/molCaramboxin
CAS:<p>Caramboxin, a neurotoxin, can induce acute kidney injury.</p>Formula:C11H13NO6Color and Shape:SolidMolecular weight:255.22LY3130481
CAS:<p>LY3130481: TARP γ-8 dependent AMPA receptor blocker; selectively targets AMPA/TARP γ-8 with 65 nM IC50.</p>Formula:C19H18N4O3SColor and Shape:SolidMolecular weight:382.44LY 215490
CAS:<p>LY 215490 is a selective AMPA receptor antagonist with neuroprotective properties in rat ischemia.</p>Formula:C13H21N5O2Purity:98%Color and Shape:SolidMolecular weight:279.34NMDA receptor antagonist-3
<p>NMDA antagonist-3: recovery rate 40% at 100 μM, low toxicity in SH-SY5Y, human stem cells.</p>Formula:C13H19N3O6Color and Shape:SolidMolecular weight:313.31BMS-986163
CAS:<p>BMS-986163, a prodrug, quickly becomes BMS-986169, a GluN2B inhibitor (Ki=4 nM, IC50=24 nM).</p>Formula:C23H28FN2O5PPurity:98%Color and Shape:SolidMolecular weight:462.45YY-23
CAS:<p>YY-23 is a selective NMDAR (containing GluN2C or GluN2D) inhibitor. By inhibiting NMDARs with GluN2D on GABAergic interneurons in the prefrontal cortex, YY-23 suppresses GABAergic neurotransmission and enhances excitatory transmission. YY-23 exhibits antidepressant activity and is useful for neurological disease research.</p>Formula:C33H54O8Color and Shape:SolidMolecular weight:578.777(RS)-AMPA hydrobromide
CAS:<p>AMPAR agonist</p>Formula:C7H11BrN2O4Purity:98%Color and Shape:SolidMolecular weight:267.08NYX-2925
CAS:<p>NYX-2925, an oral NMDAR modulator, enhances Src in mPFC. No CAMKII impact or addictive/sedative effects. Useful for CNS disorder studies.</p>Formula:C14H23N3O4Color and Shape:SolidMolecular weight:297.35Onfasprodil
CAS:<p>Onfasprodil, NR2B inhibitor & GABA regulator, potential for Alzheimer's research. (Patent CN111481543A)</p>Formula:C20H23FN2O3Color and Shape:SolidMolecular weight:358.41Macitentan (n-butyl analogue)
CAS:<p>Macitentan n-butyl analogue, an oral ETA/ETB receptor blocker, may treat IPF and PAH.</p>Formula:C20H21Br2N5O4SPurity:98%Color and Shape:SolidMolecular weight:587.29Antidepressant agent 8
CAS:<p>Antidepressant agent 8 (Compound 1f) acts as a selective antagonist for the NMDA receptor GluN1/2A (NMDA receptorGluN1/2A), with an IC50 of 2.94 μmol/L. In a hydrocortisone-induced zebrafish depression model, it demonstrates antidepressant-like effects and shows good blood-brain barrier penetration.</p>Formula:C18H23FN4OS2Color and Shape:SolidMolecular weight:394.53PDE2 inhibitor 6
CAS:<p>PDE2 inhibitor6 (Compound 1) is an orally active phosphodiesterase (PDE) inhibitor, effectively inhibiting PDE2A, PDE3B, and PDE10A2 with IC50 values of 0.95 nM, 6.17 μM (pIC50=5.21), and 87.1 nM (pIC50=7.06), respectively. It modulates AMPA receptor activity, enhances synaptic plasticity, and improves learning and memory in rat models. Furthermore, PDE2 inhibitor6 possesses blood-brain barrier permeability.</p>Formula:C20H22F2N6OColor and Shape:SolidMolecular weight:400.425Metaphit methylsulfate
CAS:<p>Metaphit methylsulfate is a specific PCP antagonist and an acylating agent for the [3H] phencyclidine binding site in rat brain homogenate. It inhibits PCP-induced motor activity through a presynaptic mechanism.</p>Formula:C19H28N2O3S2Color and Shape:SolidMolecular weight:396.567(3S,6R)-NML
CAS:<p>(3S,6R)-NML is an NMDA receptor antagonist with pIC50 values of 4.8 [GluN1-GluN2A], 4.6 [GluN1-GluN2B], 5.0 [GluN1-GluN2C], and 5.0 [GluN1-GluN2D]. It is applicable in the study of depression.</p>Formula:C20H27NOColor and Shape:SolidMolecular weight:297.435Blixeprodil
CAS:<p>Blixeprodil (GM-1020) is an orally active NMDA receptor antagonist with an affinity of Ki = 3.25 µM in rat cortical tissue. It inhibits NR1/2A-NMDAR-mediated currents in HEK293 cells with an IC50 of 1.192 µM. Blixeprodil demonstrates antidepressant effects in rat models and exhibits blood-brain barrier permeability.</p>Formula:C13H16FNOColor and Shape:SolidMolecular weight:221.271EU 1622-240
CAS:<p>EU 1622-240 is an allosteric modulator with a preference for GluN2B, GluN2C, and GluN2D, exhibiting EC50 values of 0.57, 0.82, and 1.1 μM, respectively. It possesses favorable physicochemical properties, along with in vitro stability and permeability.</p>Formula:C20H14BrF2N3O2SColor and Shape:SolidMolecular weight:478.31Lu AF90103
CAS:<p>Lu AF90103 (Compound 42e) is the methyl ester prodrug of compound 42d, capable of crossing the blood-brain barrier. Compound 42d acts as a partial agonist of the GluN1/GluN2B complex, with an efficacy of 24% and an EC50 value of 78 nM. Lu AF90103 plays a significant role in neuropsychiatric disorder research.</p>Formula:C13H15N3O3SColor and Shape:SolidMolecular weight:293.342Antidepressant agent 9
CAS:<p>Antidepressant agent 9 (Compound 24) is an orally active inhibitor of NMDAR and SERT, with IC50 values of 3.50 μM and 1044 nM, respectively. It exhibits good metabolic stability and plasma exposure, and demonstrates antidepressant-like effects in the forced swim test in mice.</p>Formula:C17H24N2Color and Shape:SolidMolecular weight:256.386Caged MK801
CAS:<p>Caged MK801 (cMK801) is a selective, noncompetitive, and irreversible blocker of the NMDA receptor open channel. The NVOC cage is compatible in neuropharmacology and does not alter the intrinsic activity of the molecule.</p>Formula:C26H24N2O6Color and Shape:SolidMolecular weight:460.48(RS)-AMPA monohydrate
CAS:<p>(RS)-AMPA monohydrate, potent glutamate analogue, selectively activates L-glutamic acid without affecting kainic acid or NMDA receptors.</p>Formula:C7H12N2O5Color and Shape:SolidMolecular weight:204.182EMD-95885
CAS:<p>EMD-95885 is a selective antagonist of NMDA receptors containing NR2B subunits, with an IC50 of 3.9 nM. It does not interact with other sites on the NMDA receptor.</p>Formula:C22H23FN2O3Color and Shape:SolidMolecular weight:382.428NMDA agonist 1
CAS:<p>NMDA agonist 1 (compound 42d) is a potent NMDA agonist with a Ki value of 96 nM. It acts as a partial agonist of the GluN1/GluN2B complex, exhibiting an EC50 value of 78 nM.</p>Formula:C12H13N3O3SColor and Shape:SolidMolecular weight:279.315Tamitinol
CAS:<p>Tamitinol is a neurotropic drug. It has been found to help symptoms of obsessive rumination in conjunction with maprotiline.</p>Formula:C12H20N2OSPurity:98%Color and Shape:SolidMolecular weight:240.37(RS)-AMPA
CAS:<p>(RS)-AMPA ((±)-AMPA) is a glutamate analog. (RS)-AMPA is an agonist of effective and selective excitatory neurotransmitter L-glutamic acid.</p>Formula:C7H10N2O4Purity:98%Color and Shape:SolidMolecular weight:186.17LY 235959
CAS:<p>LY 235959 is a NMDA receptor antagonist.</p>Formula:C11H20NO5PPurity:98%Color and Shape:SolidMolecular weight:277.25DL-AP5 lithium
CAS:<p>DL-AP5 (2-APV) lithium is a competitive antagonist of the NMDA (N-Methyl-D-aspartate) receptor. It exhibits notable analgesic activity and specifically blocks channels in the rabbit retina.</p>Formula:C5H11LiNO5PColor and Shape:SolidMolecular weight:203.06(RS)-AMPA hydrochloride
CAS:<p>(RS)-AMPA ((±)-AMPA) hydrochloride is a glutamate analog and serves as an efficient selective agonist for the excitatory neurotransmitter L-glutamic acid (L-glutamic acid). It does not interfere with the binding sites of alginate or NMDA receptors.</p>Formula:C7H11ClN2O4Color and Shape:SolidMolecular weight:222.63LY503430
CAS:<p>LY503430: Oral AMPA enhancer with nootropic, neuroprotective properties, mitigates 6-OHDA/MPTP brain damage.</p>Formula:C20H25FN2O3SPurity:98%Color and Shape:SolidMolecular weight:392.493-Methoxy PCE hydrochloride
CAS:<p>3-Methoxy PCE (3-MEO PCE) hydrochloride is an arylcyclohexylamine compound that functions as an NMDA receptor antagonist with a pKi value of 7.22.</p>Formula:C15H24ClNOColor and Shape:SolidMolecular weight:269.81Perfluoroheptanesulfonic acid
CAS:<p>Perfluoroheptanesulfonic acid (1-Perfluoroheptanesulfonic acid; Perfluoroheptanesulphonic acid) is a perfluoroalkyl substance (PFAS). This compound has been detected in landfill leachate and has been shown to induce deformities in zebrafish larvae (EC50=168.1 μM). Exposure to PFHpS in fetuses can lead to reduced birth weight.</p>Formula:C7HF15O3SColor and Shape:SolidMolecular weight:450.12BDZ-g
CAS:<p>BDZ-g: potent, selective AMPA receptor antagonist; useful for researching neurological disorders.</p>Formula:C21H21N5O2SPurity:99.97%Color and Shape:SolidMolecular weight:407.49SDZ 220-040
CAS:<p>SDZ 220-040 是一种选择性哺乳动物 NMDA 受体拮抗剂，可诱导根系生长的部分无重力模式 。</p>Formula:C16H16Cl2NO6PPurity:98.13%Color and Shape:SolidMolecular weight:420.18tert-Butyl Hydrogen Tetradecanedioate
CAS:Formula:C18H34O4Purity:>95.0%(GC)(T)Color and Shape:White to Light yellow powder to crystalMolecular weight:314.474,4'-Diethynylbiphenyl
CAS:Formula:C16H10Purity:>98.0%(GC)Color and Shape:White to Light yellow to Light orange powder to crystalMolecular weight:202.26Isobutyryl Chloride
CAS:Formula:C4H7ClOPurity:>98.0%(GC)(T)Color and Shape:Colorless to Light yellow clear liquidMolecular weight:106.554-Maleimidobutyric Acid
CAS:Formula:C8H9NO4Purity:>98.0%(GC)Color and Shape:White to Almost white powder to crystalMolecular weight:183.16N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-norvaline
CAS:Formula:C20H21NO4Purity:>98.0%(T)(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:339.39Veratramine
CAS:Formula:C27H39NO2Purity:>98.0%(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:409.61D-2-Phenylglycine
CAS:Formula:C8H9NO2Purity:>99.0%(T)Color and Shape:White to Almost white powder to crystalMolecular weight:151.17(1E,4E)-1,5-Bis[3,5-bis(methoxymethoxy)phenyl]-1,4-pentadiene-3-one
CAS:Formula:C25H30O9Purity:>97.0%(HPLC)Color and Shape:White to Yellow to Green powder to crystalMolecular weight:474.51Ref: ST-EA-CP-D73001
Discontinued productCinacalcet Related Compound E
Aromatic alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFormula:C10H11F3OColor and Shape:Colorless Clear Light Yellow Light Brown LiquidMolecular weight:204.0762Iloperidone Related Compound A ([4'-(3-Chloropropoxy)-3'-methoxy]acetophenone) (DISCONTINUED)
CAS:Halogenated, sulfonated, nitrated or nitrosated derivatives: chlordecone (iso)Formula:C12H15ClO3Color and Shape:PowderMolecular weight:242.07097Isocyclosporin A
CAS:Lactams, nesoiFormula:C62H111N11O12Color and Shape:White Off-White PowderMolecular weight:1201.84137Nisoldipine Related Compound G (Diisobutyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate) (DISCONTINUED)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C23H30N2O6Color and Shape:Yellow PowderMolecular weight:430.5Ethylhexyl Triazone Related Compound B (4-[(4,6-Bis[(4-{[(2-ethylhexyl)oxy]carbonyl}phenyl)amino]-1,3,5-triazin-2-yl)amino]benzoic acid) (DISCONTINUED)
Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFormula:C40H50N6O6Color and Shape:PowderMolecular weight:710.86Calcitonin Salmon Related Compound B (calcitonin salmon-glycine) (COLD SHIPMENT REQUIRED) (DISCONTINUED)
CAS:<p>Polypeptide, protein and glycoprotein hormones, their derivatives and structural analogues, nesoi</p>Formula:C147H242N44O50S2Color and Shape:Colorless LiquidMolecular weight:3487.71879Drometrizole Trisiloxane Related Compound E (2-(2H-Benzotriazol-2-yl)-6-{3-[bis(trimethylsiloxy)methylsilyl]isobutyl}-O1-[bis(trimethylsiloxy)methylsilyl]-p-cresol) (DISCONTINUED)
CAS:Aromatic or modified aromatic drugs with nitrogen heterFormula:C31H59N3O5Si6Color and Shape:Pale Yellow LiquidMolecular weight:722.33Fentanyl Related Compound B (4-Anilinopiperidine)
CAS:Controlled ProductCompounds containing an unfused pyridine ring in the structure, nesoiFormula:C11H16N2Color and Shape:White PowderMolecular weight:176.13135Cinacalcet Related Compound B
Aromatic monoamines and their derivatives, salts thereof, nesoiFormula:C32H31F6NColor and Shape:Brown LiquidMolecular weight:543.6Drometrizole Trisiloxane Related Compound A (2-(2H-Benzotriazol-2-yl)-6-(isobuten-1-yl)-p-cresol) (DISCONTINUED)
CAS:<p>Aromatic or modified aromatic drugs with nitrogen heter</p>Formula:C17H17N3OColor and Shape:Yellow PowderMolecular weight:279.13716Modafinil Related Compound E (Bis(diphenylmethyl)disulfide) (DISCONTINUED)
CAS:Other aromatic organo-sulfur compounds (excluding pesticides)Formula:C26H22S2Color and Shape:White PowderMolecular weight:398.11629N-Nitroso Dabigatran Etexilate Solution (1 mL ) (ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)(nitroso)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate)
CAS:<p>Compounds containing an unfused pyridine ring in the structure, nesoi</p>Formula:C34H40N8O6Color and Shape:Colorless LiquidMolecular weight:656.30708Vortioxetine Related Compound I
CAS:<p>Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoi</p>Formula:C18H22N2SMolecular weight:298.15037Lufenuron Related Compound G (2,5-Dichloro-4-[3-(2,6-difluorobenzoyl)ureido]phenyl phenyl carbonate)
CAS:Ureines and their derivatives; salts thereofFormula:C21H12Cl2F2N2O5Color and Shape:PowderMolecular weight:480.00913Modafinil Related Compound B (2-[(diphenylmethyl)sulfonyl]acetamide) (DISCONTINUED)
CAS:Other aromatic organo-sulfur compounds (excluding pesticides)Formula:C15H15NO3SColor and Shape:White PowderMolecular weight:289.07726Iscotrizinol Related Compound G (2-Ethylhexyl 4-{4-[(4-{[4-(tert-butylcarbamoyl)phenyl]amino}-6-[(4-{[(2-ethylhexyl)oxy]carbonyl}phenyl)amino]-1,3,5-triazin-2-yl)amino]benzamido}benzoate) (DISCONTINUED)
<p>Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structure</p>Formula:C51H64N8O6Color and Shape:PowderMolecular weight:884.49488Rivaroxaban Open Ring ((R)-5-chloro-N-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)thiophene-2-carboxamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C18H20ClN3O4SColor and Shape:Off-White SolidMolecular weight:409.89Clavam-2-carboxylate Potassium
CAS:<p>Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoi</p>Formula:C6H6KNO4Color and Shape:White FilmMolecular weight:194.99339Cidofovir Related Compound A (1-[(S)-3-Hydroxy-2-(O-ethylphosphonomethoxy)propyl]cytosine)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormula:C10H18N3O6PColor and Shape:White Off-White PowderMolecular weight:307.09332Eprosartan Related Compound A ((E)-3-(2-butyl-1H-imidazol-5-yl)-2-(thiophen-2-ylmethyl)acrylic acid hydrochloride) (DISCONTINUED)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C15H18N2O2S·HClColor and Shape:Off-White PowderMolecular weight:290.1089Dihydrodaunorubicin Hydrochloride ((8S,10S)-10-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride) (DISCONTINUED)
Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C27H31NO10·HClColor and Shape:PowderMolecular weight:565.171472-Ethylhexan-1-ol (DISCONTINUED)
CAS:2-ethylhexan-1-ol (octyl alcohol)Formula:C8H18OColor and Shape:LiquidMolecular weight:130.22 g/molDeacetylnorgestimate ((E)- and (Z)-17-deacetyl norgestimate mixture) (DISCONTINUED)
CAS:<p>Estrogens and progestins</p>Formula:C21H29NO2Color and Shape:White PowderMolecular weight:327.21983Nisoldipine Related Compound C (Isobutyl (Z)-2-(2-nitrobenzylidene)-3-oxobutanoate) (DISCONTINUED)
Carboxylic acids with aldehyde or ketone function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids andtheir derivFormula:C15H17NO5Color and Shape:Pale Yellow SolidMolecular weight:291.11067Mirtazapine Related Compound B (1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine 2-oxide monohydrate)
CAS:<p>Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoi</p>Formula:C17H19N3O·H2OColor and Shape:Off-White White PowderMolecular weight:281.15281Chlorothiophene carboxylic acid (5-chlorothiophene-2-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C5H3ClO2SColor and Shape:Off-White Pale Yellow SolidMolecular weight:162.59 g/molNisoldipine Related Compound D (3-Isobutyl 5-methyl 2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxylate) (DISCONTINUED)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C20H22N2O6Color and Shape:Pale Yellow SolidMolecular weight:386.14779Eprosartan Related Compound C (2-(thiophen-2-ylmethyl)malonic acid) (DISCONTINUED)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C8H8O4SColor and Shape:White PowderMolecular weight:200.21Oxaliplatin Related Compound B ([SP-4-2-(1R-trans)]-(1,2-cyclohexanediamine-N,N') dinitratoplatinum(II))
CAS:Inorganic or organic compounds of precious metals, whetFormula:C6H14N4O6PtColor and Shape:White Pale Yellow Crystalline PowderMolecular weight:433.05613Nefazodone Related Compound A (1-(3-chlorophenyl)-4-(3-chloropropyl)-piperazine hydrochloride) (PLANNED TO BE DISCONTINUED)
CAS:Compounds containing a pyrimidine ring (whether or notFormula:C13H18Cl2N2·HClColor and Shape:White PowderMolecular weight:272.0847Buspirone Related Compound L (8-(4-Chlorobutyl)-8-azaspiro[4.5]decane-7,9-dione)
CAS:<p>Imides and their derivatives (excluding sacharin), salt thereof</p>Formula:C13H20ClNO2Color and Shape:Colorless Clear Light Yellow LiquidMolecular weight:257.11826Modafinil Related Compound C (2-[(diphenylmethyl)sulfenyl]acetamide)
CAS:Other aromatic organo-sulfur compounds (excluding pestiFormula:C15H15NOSColor and Shape:White PowderMolecular weight:257.35Ethylhexyl Triazone Related Compound A (2-ethylhexyl 4-aminobenzoate) (DISCONTINUED)
CAS:Aromatic amino-acids and their esters, other than thoseFormula:C15H23NO2Color and Shape:PlatesMolecular weight:249.35Amiodarone Related Compound C
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C25H30INO3Molecular weight:519.12704Proguanil Related Compound C (1,5-bis(4-chlorophenyl)biguanide hydrochloride)
CAS:Aromatic imines and their derivatives, salts thereofFormula:C14H13Cl2N5·HClColor and Shape:White Crystalline PowderMolecular weight:321.0548Trospium Chloride Related Compound B ((1R,3r,5S)-8-azabicyclo[3.2.1]octan-3-yl hydroxydiphenylacetate hydrochloride)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C21H23NO3Color and Shape:White Off-White SolidMolecular weight:337.16779Dalfampridine Related Compound A (4-Aminopyridine 1-oxide)
CAS:<p>Compounds containing an unfused pyridine ring in the structure, nesoi</p>Formula:C5H6N2OColor and Shape:White SolidMolecular weight:110.04801Eprosartan Related Compound D (4-(bromomethyl)benzoic acid) (DISCONTINUED)
CAS:Aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacid and their derivatives not elsewhere specified or includedFormula:C8H7BrO2Color and Shape:White PowderMolecular weight:213.96294Moexipril Related Compound A ((3S)-2-{(2S)-N-[(1S)-1-Carboxy-3-phenylpropyl]alanyl}-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid)
CAS:Compounds (excluding drugs and pesticides) containing aFormula:C25H30N2O7Color and Shape:PowderMolecular weight:470.52Eprosartan Related Compound B (3-(thiophen-2-yl)propanoic acid) (DISCONTINUED)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C7H8O2SColor and Shape:White Beige SolidMolecular weight:156.0245Orlistat Related Compound D (N-formyl-L-leucine (3S,4R,6S)-3-hexyl-2-oxo-6-undecyltetrahydro-2H-pyran-4-yl ester) (DISCONTINUED)
CAS:Lactones, nesoiFormula:C29H53NO5Color and Shape:LiquidMolecular weight:495.73Iscotrizinol Related Compound C (2-Ethylhexyl 4-[(4-{[4-(tert-butylcarbamoyl)phenyl]amino}-6-chloro-1,3,5-triazin-2-yl)amino]benzoate) (DISCONTINUED)
<p>Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structure</p>Formula:C29H37ClN6O3Color and Shape:White Off-White PowderMolecular weight:552.26157Nisoldipine Related Compound E (3-Isobutyl 5-methyl 2,6-dimethyl-4-(2-nitrosophenyl)pyridine-3,5-dicarboxylate) (DISCONTINUED)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C20H22N2O5Color and Shape:Green SolidMolecular weight:370.4Iscotrizinol Related Compound I (Bis(2-ethylhexyl) 4,4'-{[6-({4-[(4-{[(2-ethylhexyl)oxy]carbonyl}phenyl)carbamoyl]phenyl}amino)-1,3,5-triazine-2,4-diyl]bis(azanediyl)}dibenzoate) (DISCONTINUED)
Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFormula:C55H71N7O7Color and Shape:White PowderMolecular weight:941.5415Ioxilan Related Compound A (5-amino-2,4,6-triiodo-3 N-(2-hydroxyethyl)carbamoyl benzoic acid) (DISCONTINUED)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormula:C10H9I3N2O4Color and Shape:White PowderMolecular weight:601.76965Eprosartan Related Compound E (4-(hydroxymethyl)benzoic acid) (DISCONTINUED)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc not elsewhere specified or includedFormula:C8H8O3Color and Shape:Beige White PowderMolecular weight:152.15Modafinil Related Compound D (Bis(diphenylmethyl)ether) (DISCONTINUED)
CAS:Aromatic ethers and their halogenated, sulfonated, nitrated or nitrosated derivativesFormula:C26H22OColor and Shape:White PowderMolecular weight:350.45
![[1-4]Acid-Cetrorelix](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FST-EA%2Fthumb-webp%2FEA-CP-C267014.webp&w=3840&q=75)
![2,2'-(Thiobis(2-hydroxy-5,1-phenylene))bis(4H-benzo[e][1,3]oxazin-4-one)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIT183623.webp&w=3840&q=75)
![N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-norvaline](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3B%2Fthumb-webp%2FF1117.webp&w=3840&q=75)
![(1E,4E)-1,5-Bis[3,5-bis(methoxymethoxy)phenyl]-1,4-pentadiene-3-one](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3B%2Fthumb-webp%2FB4823.webp&w=3840&q=75)
![Mirtazapine Related Compound B (1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]be…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1444235.webp&w=3840&q=75)
![Buspirone Related Compound L (8-(4-Chlorobutyl)-8-azaspiro[4.5]decane-7,9-dione)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1078824.webp&w=3840&q=75)
![Modafinil Related Compound C (2-[(diphenylmethyl)sulfenyl]acetamide)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1445368.webp&w=3840&q=75)
![Moexipril Related Compound A ((3S)-2-{(2S)-N-[(1S)-1-Carboxy-3-phenylpropyl]alanyl}-1,2,3,4-tetrah…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1445608.webp&w=3840&q=75)
